{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T09:02:22Z","timestamp":1794646942910,"version":"4.9.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"52","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.vaccine.2022.10.069","type":"journal-article","created":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T20:41:46Z","timestamp":1668199306000},"page":"7693-7702","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["A novel multi-epitope vaccine of HPV16 E5E6E7 oncoprotein delivered by HBc VLPs induced efficient prophylactic and therapeutic antitumor immunity in tumor mice model"],"prefix":"10.1016","volume":"40","author":[{"given":"Wang","family":"Qi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Qingfeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhang","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Maolin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhang","family":"Zhihui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Du","family":"Wangqi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhu","family":"Shanli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Jun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Pengfei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhang","family":"Lifang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.vaccine.2022.10.069_b0005","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"9376","key":"10.1016\/j.vaccine.2022.10.069_b0010","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1016\/S0140-6736(03)13778-6","article-title":"Cervical cancer","volume":"361","author":"Waggoner","year":"2003","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.vaccine.2022.10.069_b0015","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.bpobgyn.2017.09.008","article-title":"Therapeutic HPV vaccines","volume":"47","author":"Hancock","year":"2018","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"17","key":"10.1016\/j.vaccine.2022.10.069_b0020","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1042\/CS20160786","article-title":"The human papillomavirus replication cycle, and its links to cancer progression: a comprehensive review","volume":"131","author":"Graham","year":"2017","journal-title":"Clin Sci (Lond)"},{"issue":"7","key":"10.1016\/j.vaccine.2022.10.069_b0030","doi-asserted-by":"crossref","first-page":"384","DOI":"10.3390\/medicina55070384","article-title":"Key molecular events in cervical cancer development","volume":"55","author":"Balasubramaniam","year":"2019","journal-title":"Medicina (Kaunas)"},{"issue":"3","key":"10.1016\/j.vaccine.2022.10.069_b0035","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/j.1525-1438.2007.01029.x","article-title":"Immunization of mice with plasmids coexpressing HPV16 E5 and the novel oncogene hWAPL","volume":"18","author":"Cao","year":"2008","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.vaccine.2022.10.069_b0040","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.3389\/fimmu.2018.02478","article-title":"Advances in designing and developing vaccines drugs and therapeutic approaches to counter human papilloma virus","volume":"9","author":"Dadar","year":"2018","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2022.10.069_b0045","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/cmi.2017.92","article-title":"Multi-epitope vaccines: a promising strategy against tumors and viral infections","volume":"15","author":"Zhang","year":"2018","journal-title":"Cell Mol Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2022.10.069_b0050","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41541-020-00274-4","article-title":"An epitope-based malaria vaccine targeting the junctional region of circumsporozoite protein","volume":"6","author":"Jelinkova","year":"2021","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.vaccine.2022.10.069_b0055","doi-asserted-by":"crossref","first-page":"e6185","DOI":"10.7717\/peerj.6185","article-title":"Application of built-in adjuvants for epitope-based vaccines","volume":"6","author":"Lei","year":"2019","journal-title":"PeerJ"},{"issue":"1","key":"10.1016\/j.vaccine.2022.10.069_b0060","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3892\/etm.2013.1374","article-title":"Human papillomavirus oncoproteins and apoptosis (Review)","volume":"7","author":"Jiang","year":"2014","journal-title":"Exp Ther Med"},{"issue":"13","key":"10.1016\/j.vaccine.2022.10.069_b0065","doi-asserted-by":"crossref","first-page":"3544","DOI":"10.7150\/thno.24607","article-title":"A novel HPV16 E7-affitoxin for targeted therapy of HPV16-induced human cervical cancer","volume":"8","author":"Jiang","year":"2018","journal-title":"Theranostics"},{"issue":"3","key":"10.1016\/j.vaccine.2022.10.069_b0070","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s10529-020-02792-6","article-title":"Development of HPV(16,18,31,45) E5 and E7 peptides-based vaccines predicted by immunoinformatics tools","volume":"42","author":"Namvar","year":"2020","journal-title":"Biotechnol Lett"},{"issue":"23","key":"10.1016\/j.vaccine.2022.10.069_b0075","doi-asserted-by":"crossref","first-page":"3096","DOI":"10.1016\/j.vaccine.2017.04.031","article-title":"Evaluation of tandem Chlamydia trachomatis MOMP multi-epitopes vaccine in BALB\/c mice model","volume":"35","author":"Jiang","year":"2017","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2022.10.069_b0080","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.addr.2012.09.039","article-title":"Fusion protein linkers: property, design and functionality","volume":"65","author":"Chen","year":"2013","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.vaccine.2022.10.069_b0085","doi-asserted-by":"crossref","first-page":"592","DOI":"10.3389\/fimmu.2019.00592","article-title":"Immunogenicity of a virus-like-particle vaccine containing multiple antigenic epitopes of Toxoplasma gondii against acute and chronic toxoplasmosis in mice","volume":"10","author":"Guo","year":"2019","journal-title":"Front Immunol"},{"issue":"23","key":"10.1016\/j.vaccine.2022.10.069_b0090","doi-asserted-by":"crossref","first-page":"3096","DOI":"10.1016\/j.vaccine.2017.04.031","article-title":"Evaluation of tandem Chlamydia trachomatis MOMP multi-epitopes vaccine in BALB\/c mice model","volume":"35","author":"Jiang","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.10.069_b0095","doi-asserted-by":"crossref","first-page":"6813","DOI":"10.2147\/IJN.S143264","article-title":"Engineered outer membrane vesicle is potent to elicit HPV16E7-specific cellular immunity in a mouse model of TC-1 graft tumor","volume":"12","author":"Wang","year":"2017","journal-title":"Int J Nanomedicine"},{"issue":"3","key":"10.1016\/j.vaccine.2022.10.069_b0100","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/s41587-019-0390-x","article-title":"Peptide\u2013TLR-7\/8a conjugate vaccines chemically programmed for nanoparticle self-assembly enhance CD8 T-cell immunity to tumor antigens","volume":"38","author":"Lynn","year":"2020","journal-title":"Nat Biotechnol"},{"issue":"10","key":"10.1016\/j.vaccine.2022.10.069_b0105","doi-asserted-by":"crossref","first-page":"e0205933","DOI":"10.1371\/journal.pone.0205933","article-title":"A comprehensive in silico analysis for identification of therapeutic epitopes in HPV16, 18, 31 and 45 oncoproteins","volume":"13","author":"Panahi","year":"2018","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2022.10.069_b0110","first-page":"2417","article-title":"Chimeric HBcAg virus-like particles presenting a HPV 16 E7 epitope significantly suppressed tumor progression through preventive or therapeutic immunization in a TC-1-grafted mouse model","volume":"11","author":"Chu","year":"2016","journal-title":"Int J Nanomed"},{"issue":"7","key":"10.1016\/j.vaccine.2022.10.069_b0115","doi-asserted-by":"crossref","first-page":"459","DOI":"10.2217\/imt-2019-0196","article-title":"Development of multiepitope therapeutic vaccines against the most prevalent high-risk human papillomaviruses","volume":"12","author":"Panahi","year":"2020","journal-title":"Immunotherapy"},{"issue":"1","key":"10.1016\/j.vaccine.2022.10.069_b0120","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.03224-20","article-title":"Development of DNA vaccine targeting E6 and E7 proteins of human papillomavirus 16 (HPV16) and HPV18 for immunotherapy in combination with recombinant vaccinia boost and PD-1 antibody","volume":"12","author":"Peng","year":"2021","journal-title":"mBio"},{"issue":"3","key":"10.1016\/j.vaccine.2022.10.069_b0125","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1002\/ijc.22312","article-title":"Identification of an HLA-A24-restricted cytotoxic T lymphocyte epitope from human papillomavirus type-16 E6: the combined effects of bortezomib and interferon-gamma on the presentation of a cryptic epitope","volume":"120","author":"Morishima","year":"2007","journal-title":"Int J Cancer"},{"issue":"16","key":"10.1016\/j.vaccine.2022.10.069_b0130","doi-asserted-by":"crossref","first-page":"8468","DOI":"10.1128\/JVI.78.16.8468-8476.2004","article-title":"Development of a DNA vaccine targeting human papillomavirus type 16 oncoprotein E6","volume":"78","author":"Peng","year":"2004","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2022.10.069_b0135","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/ijc.28968","article-title":"Identification of promiscuous HPV16-derived T helper cell epitopes for therapeutic HPV vaccine design","volume":"136","author":"Grabowska","year":"2015","journal-title":"Int J Cancer"},{"issue":"2","key":"10.1016\/j.vaccine.2022.10.069_b0140","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.molimm.2014.12.007","article-title":"A novel \u201cpriming-boosting\u201d strategy for immune interventions in cervical cancer","volume":"64","author":"Liao","year":"2015","journal-title":"Mol Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2022.10.069_b0145","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s11912-018-0680-3","article-title":"Targeted agents in cervical cancer: beyond bevacizumab","volume":"20","author":"Marquina","year":"2018","journal-title":"Curr Oncol Rep"},{"issue":"1","key":"10.1016\/j.vaccine.2022.10.069_b0150","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.nano.2018.09.004","article-title":"Protein-based nanoparticles in cancer vaccine development","volume":"15","author":"Neek","year":"2019","journal-title":"Nanomedicine"},{"issue":"12","key":"10.1016\/j.vaccine.2022.10.069_b0155","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1002\/jmv.25554","article-title":"Artificially designed hepatitis B virus core particles composed of multiple epitopes of type A and O foot-and-mouth disease virus as a bivalent vaccine candidate","volume":"91","author":"Lei","year":"2019","journal-title":"J Med Virol"},{"issue":"51","key":"10.1016\/j.vaccine.2022.10.069_b0160","doi-asserted-by":"crossref","first-page":"6464","DOI":"10.1016\/j.vaccine.2016.11.026","article-title":"Influenza H7N9 LAH-HBc virus-like particle vaccine with adjuvant protects mice against homologous and heterologous influenza viruses","volume":"34","author":"Zheng","year":"2016","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2022.10.069_b0165","doi-asserted-by":"crossref","first-page":"e0138722","DOI":"10.1371\/journal.pone.0138722","article-title":"Attenuated recombinant influenza A virus expressing HPV16 E6 and E7 as a novel therapeutic vaccine approach","volume":"10","author":"Jindra","year":"2015","journal-title":"PLoS ONE"},{"issue":"19","key":"10.1016\/j.vaccine.2022.10.069_b0170","doi-asserted-by":"crossref","first-page":"9083","DOI":"10.1128\/JVI.74.19.9083-9089.2000","article-title":"Induction of CD8 T Cells by vaccination with recombinant adenovirus expressing human papillomavirus type 16 E5 gene reduces tumor growth","volume":"74","author":"Dai-Wei Liu","year":"2000","journal-title":"J Virol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22013275?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22013275?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:20:54Z","timestamp":1759404054000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X22013275"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":33,"journal-issue":{"issue":"52","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S0264410X22013275"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.10.069","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel multi-epitope vaccine of HPV16 E5E6E7 oncoprotein delivered by HBc VLPs induced efficient prophylactic and therapeutic antitumor immunity in tumor mice model","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.10.069","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}